Letko, Brosseau & Associates’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-453
| Closed | -$12.7K | – | 104 |
|
|
2024
Q2 | $12.7K | Hold |
453
| – | – | ﹤0.01% | 103 |
|
|
2024
Q1 | $136K | Hold |
453
| – | – | ﹤0.01% | 99 |
|
|
2023
Q4 | $107K | Hold |
453
| – | – | ﹤0.01% | 92 |
|
|
2023
Q3 | $67.9K | Hold |
453
| – | – | ﹤0.01% | 96 |
|
|
2023
Q2 | $78.7K | Hold |
453
| – | – | ﹤0.01% | 92 |
|
|
2023
Q1 | $57K | Buy |
+453
| New | +$57K | ﹤0.01% | 88 |
|